ArticleGenes, chromosomes & cancer2024
A challenging case of aggressive composite hemangioendothelioma with neuroendocrine differentiation and PTBP1::MAML2 fusion.
Christophe Bontoux, Anna Vigier, Thibaud Valentin, Charlotte Syrykh, Aurore Siegfried, Céline Basset, Jean Mourlanette, Hadrien Reboul, Solène Evrard, Anne Gomez-Mascard
Abstract readLetterComment
In one paragraphArticle in Genes, chromosomes & cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
10 authors.
Christophe BontouxDepartment of Pathology, Cancer University Institute of Toulouse-Oncopole, University Hospital of Toulouse, Toulouse, France.ORCID 0000-0001-5446-6197 Anna VigierDepartment of Pathology, Cancer University Institute of Toulouse-Oncopole, University Hospital of Toulouse, Toulouse, France.
Thibaud ValentinOncoSarc, INSERM U1037, Cancer Research Center in Toulouse, Toulouse, France.
Charlotte SyrykhDepartment of Pathology, Cancer University Institute of Toulouse-Oncopole, University Hospital of Toulouse, Toulouse, France.ORCID 0000-0002-3201-6109 Aurore SiegfriedDepartment of Pathology, Cancer University Institute of Toulouse-Oncopole, University Hospital of Toulouse, Toulouse, France.
Céline BassetDepartment of Pathology, Cancer University Institute of Toulouse-Oncopole, University Hospital of Toulouse, Toulouse, France.
Jean MourlanetteUniversity of Toulouse III Paul Sabatier, Toulouse, France.
Hadrien ReboulDepartment of Pathology, Cancer University Institute of Toulouse-Oncopole, University Hospital of Toulouse, Toulouse, France.
Solène EvrardDepartment of Pathology, Cancer University Institute of Toulouse-Oncopole, University Hospital of Toulouse, Toulouse, France.
Anne Gomez-MascardDepartment of Pathology, Cancer University Institute of Toulouse-Oncopole, University Hospital of Toulouse, Toulouse, France.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
HemangioendotheliomaOncogene Proteins, FusionTrans-ActivatorsCell DifferentiationDNA-Binding ProteinsFemaleHeterogeneous-Nuclear RibonucleoproteinsHumansMalePolypyrimidine Tract-Binding ProteinTranscription FactorsDNA-Binding ProteinsHeterogeneous-Nuclear RibonucleoproteinsMAML2 protein, humanOncogene Proteins, FusionPolypyrimidine Tract-Binding ProteinTrans-ActivatorsTranscription Factors
What OpenQuestion holds
Textmetadata
Read underepoch 390